Rediscovery of Caffeine: An Excellent Drug for Improving Patient Outcomes while Fighting WARS.

Curr Med Chem

Department of Endocrinology, Shanghai Gongli Hospital, The Second Military Medical University, Shanghai 200135, China.

Published: September 2021

The COVID-19 (here specifically called Worldwide Acute Respiratory Syndrome, WARS) pandemic is surging worldwide. Unfortunately, no specific drug meets the urgent need to fight this pandemic, leading to thousands of deaths. The theory of host-directed therapies (HDTs) is viewed as the ideal means to rephrase the treatment of infectious diseases. However, related drugs based on this theory have not been identified. Previously, we realized that caffeine is the ligand of type 2 taste receptors (TAS2Rs), which play a critical role in host defense. Here, we gathered data on caffeine acting as an immunomodulator. Unexpectedly, we found that caffeine can fight WARS by acting on multiple organs, which may prevent the virus from entering the cell, stimulate the phagocytosis of macrophages, enhance breathing, and inhibit the cytokine storm. Thus, the immunoprotective effects of caffeine can improve the therapeutic outcomes in patients infected with coronavirus. Collectively, we report that caffeine, an FDA-approved, highly safe, inexpensive, and widely available drug, could be an excellent HDT for battling WARS.

Download full-text PDF

Source
http://dx.doi.org/10.2174/0929867327666201103162810DOI Listing

Publication Analysis

Top Keywords

caffeine
5
rediscovery caffeine
4
caffeine excellent
4
excellent drug
4
drug improving
4
improving patient
4
patient outcomes
4
outcomes fighting
4
wars
4
fighting wars
4

Similar Publications

Background: Understanding the impact of caffeine intake on body composition is a topic of growing research interest. The article "Association Between Caffeine Intake and Fat-Free Mass Index: A Retrospective Cohort Study" by Tian et al. explored this relationship, highlighting a positive correlation between caffeine consumption and fat-free mass index (FFMI).

View Article and Find Full Text PDF

Purpose: To determine the role of topical caffeine in slowing progression of myopia, both as a standalone treatment and in combination with atropine.

Methods: In a prospective, randomized, dispensing clinical trial, 96 children with myopia, aged 6-13 years, spherical equivalent (SE) from -0.50 diopters (D) to -6.

View Article and Find Full Text PDF

Threshold determination forms an integral part of sensory and consumer studies applied for product control and development. The authors examined the potential of an impedimetric electronic tongue to discriminate basic tastes and consider limitations pertaining to the sensory evaluation process. Three samples at lower, medium, and higher concentration levels of basic taste compounds were prepared and subjected to consumer studies (n = 60) using the difference from-control (DFC) test.

View Article and Find Full Text PDF

1-Methylxanthine (1-MX) is the major metabolite of caffeine and paraxanthine and might contribute to their activity. 1-MX is an adenosine receptor antagonist and increases the release and survivability of neurotransmitters; however, no study has addressed the potential physiological effects of 1-MX ingestion. The aim of this study was to compare the effect of 1-MX on memory and related biomarkers in rats compared to control.

View Article and Find Full Text PDF

This study examines pharmaceutical residues in the seawater of west Spitsbergen fjords, using indicator compounds that represent different types of medications with various therapeutic uses (sulfamethoxazole, trimethoprim, carbamazepine, diclofenac, and caffeine). Over three years (summer 2018-2021), trimethoprim, carbamazepine, diclofenac, and caffeine were detected in the investigated fjords (Hornsund, Adventfjorden, Grønnfjorden, Isfjorden, and Kongsfjorden), with diclofenac and caffeine being the most common. Sulfamethoxazole was below the limit of detection in all samples.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!